Table 2 Co-morbidities, clinical and cardiovascular findings among CAD Group represented as frequency (n, %)
Variable | CAD Cases | P-value |
|---|---|---|
Diabetes | ||
Diabetics | 33 (45.2%) | > 0.05 ns |
Non-diabetics | 40 (54.8%) | |
Hypertension | ||
Hypertensive | 32 (43.8%) | > 0.05 ns |
Non-hypertensive | 41 (56.2%) | |
Ischemic heart disease | ||
Ischemic heart disease | 41 (56.2%) | > 0.05 ns |
Non-ischemic heart disease | 31 (42.5%) | |
BSA | 1.84 ± 0.18 | |
Systole | 127.33 ± 17.28 | |
Diastole | 81.37 ± 16.14 | |
LVEF | 46.58 ± 13.25 | |
LVEF grade | ||
Normal | 22 (30.14%) | < 0.001*** |
Mild | 15 (20.55%) | |
Moderate | 24 (32.88%) | |
Severe | 12 (16.44%) | |
WMSI | 1.49 ± 0.44 | |
Diastolic function | ||
Normal | 4 (5.5%) | < 0.001*** |
Mild | 42 (57.5%) | |
Moderate | 22 (30.1%) | |
Severe | 5 (6.8%) | |